Introduction
============

*Burkholderia pseudomallei* is a Gram-negative pathogen which is the causative agent of melioidosis, a serious invasive disease of humans and animals. Melioidosis is endemic to northern Australia, Papua New Guinea, Southeast Asia, most of the Indian subcontinent and southern China, Hong Kong, and Taiwan. It is well recognized that *B. pseudomallei* is "highly endemic" to northeast Thailand, northern Australia, Singapore, and Malaysia where many cases of melioidosis are diagnosed each year (Currie et al., [@B29]). Sporadic cases have also been reported in other regions including Brazil, Puerto Rico, and New Caledonia (Dorman et al., [@B34]; Aardema et al., [@B1]; Le Hello et al., [@B77]; Barth et al., [@B10]). *B. pseudomallei* is a natural inhabitant of rice paddies, still or stagnant waters, and moist tropical soils (Brett and Woods, [@B16]). Despite several decades of research on prevention and treatment, mortality from melioidosis remains very high (50% in northeast Thailand and 19% in Australia; Peacock [@B89]). Alarmingly, the mortality associated with septic shock remains close to 90% (Stone, [@B121]). Melioidosis accounts for 20% of all community-acquired septicemias in northeast Thailand (Chaowagul et al., [@B22]) and 32% of community-acquired bacteremic pneumonia and 6% of all bacteremias in northern Australia (Douglas et al., [@B35]).

Since the 1990s, it has been well accepted that a key component of the pathogenesis of *B. pseudomallei* is its ability to survive intracellularly in both phagocytic and non-phagocytic cells (Jones et al., [@B65]). The importance of intracellular survival is paramount, as this remarkable feature allows the bacterium to establish an infection while avoiding host immune responses. Indeed, the ability of *B. pseudomallei* to survive intracellularly explains numerous features of melioidosis, including latency, recrudescence, and treatment difficulty. Latency periods of more than 60 years have been documented (Ngauy et al., [@B85]). Activation of a latent infection is usually due to a decrease in the individual's immunocompetence and can result in an acute, fulminant, and fatal infection (Koponen et al., [@B74]). Relapse is common in melioidosis patients; recrudescence of melioidosis following apparent clinical resolution of the primary infection usually results from reactivation rather than reinfection (Haase et al., [@B54]; Maharjan et al., [@B78]).

*Burkholderia pseudomallei* utilizes numerous strategies that enable it to survive in such a specialized niche as the intracellular environment (Figure [1](#F1){ref-type="fig"}). This review will focus on these strategies for intracellular survival, from adhesion, invasion, and endosome escape to actin-based motility, formation of multi-nucleated giant cells (MNGC), evasion of host cell autophagy, and interaction of *B. pseudomallei* with host cell ubiquitination mechanisms.

![**Schematic representation of selected steps in the intracellular lifestyle of *B. pseudomallei***. *B. pseudomallei* can be internalized by either phagocytic or non-phagocytic cells. In non-phagocytic cells PilA and the adhesins BoaA and BoaB are critical for uptake. For the internalization step in non-phagocytic cells the Bsa T3SS structural proteins BipD (translocator), BsaQ (structural component), and BopE (effector) are required. The IrlRS two-component signal transduction system is predicted to regulate the expression of other key gene(s) involved in internalization. For internalization in phagocytic cells the Bsa T3SS putative effector BopA and the alternate sigma factor RpoS play minor roles. The Bsa T3SS structural proteins BsaZ, BsaQ, and BsaU, the translocator protein BipD and the putative effector BopA are critical for membrane disruption and escape from the endocytic vesicle. Once in the cytoplasm *B. pseudomallei* can replicate and move by actin-based motility in a BimA-dependent fashion. *B. pseudomallei* LPS only weakly stimulates IFN secretion, which results in reduced iNOS expression and NO production. Furthermore, *B. pseudomallei* induces expression of suppressor of cytokine signaling 3 (SOCS3) and cytokine-inducible Src homology 2-containing (CIS) proteins which inhibit the Janus kinases -- signal transducers and activators of transcription (JAK--STAT) signaling pathway and concomitant iNOS activation. Purine (PurM, PurN), histidine (HisF), and *para*-aminobenzoate (PabB) biosynthetic pathways are important for intracellular replication and survival, while the *B. pseudomallei* T6SS-1 Hcp protein, the alternate sigma factor RpoS, and the Bsa T3SS protein BipB are involved in stimulating cell-to-cell fusion and the formation of MNGC. NOD2 refers to nucleotide-binding oligomerization domain-containing protein 2. Green arrows are used to indicate progression of time. Red T-bar arrows indicate inhibitory interactions. Secretion system components are color coded with effectors in purple, translocators in black, and structural components in red.](fmicb-02-00170-g001){#F1}

The Adhesion of *B. pseudomallei* to Host Cells: An Early Step in Pathogenesis
==============================================================================

It is a *sine qua non* that the internalization of pathogenic bacteria by mammalian cells is preceded by adhesion of the bacteria to the cell surface. It is therefore somewhat surprising that a detailed knowledge at the molecular level of the interaction of *B. pseudomallei* with the eukaryotic cell surface is less developed than that for many other bacterial pathogens. Comparisons between different studies using *B. pseudomallei* are difficult because of the use of different cell lines, bacterial strains, multiplicities of infection, and experimental conditions by different research groups. Nevertheless, the ability to adhere to the cell has been demonstrated to correlate with virulence in a number of studies. Five *B. pseudomallei* strains all adhered more strongly to human A549 lung epithelial cells than did five strains of the non-pathogenic species *B. thailandensis* (Kespichayawattana et al., [@B69]). The increased adhesion correlated with subsequent increased invasion and cytopathic effect, but, as in many other studies, the molecular basis for the difference was not determined. Likewise, a study which inferred, through inhibition studies, the attachment of *B. pseudomallei* to the GM1--GM2 glycosphingolipid ganglioside on undefined primary human pharyngeal epithelial cells did not investigate the bacterial component(s) involved (Gori et al., [@B51]).

Based on limited evidence derived from electron microscopy (EM), Ahmed et al. ([@B2] suggested that the adhesion of *B. pseudomallei* to an undefined population of primary human "pharyngeal" cells involved a bacterial surface structure which was designated, without supporting evidence, as capsular polysaccharide. Paradoxically, a more recent study with a genetically defined acapsular mutant (Reckseidler et al., [@B99]) found that the lack of capsule resulted in enhanced internalization into A549 and HeLa cells (Phewkliang et al., [@B92]); there was no effect on intracellular replication or cytotoxicity. Thus, while capsule clearly plays a key role in the ability of *B. pseudomallei* to cause disease (Reckseidler et al., [@B99]; Lazar Adler et al., [@B76]), there is no clear evidence for a role in cell adhesion or invasion (Table [1](#T1){ref-type="table"}).

###### 

**Characterization of *B. pseudomallei* mutants with defects in intracellular life cycle**.

  Ability for                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ---------------------------------------------------------------- ------------------------------------------------------- ----------------------------------- ------------------------------------------- --------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------------- ------------------------------- ------------------------------------------------ -------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  **INVOLVED IN ADHERENCE**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  *pilA*                                                           Pilin subunit                                           K96243 and 08                       ↓: A549, BEAS2-B, RPMI-2650, and ME-180     ND                                            ND                                                          ND                                                     ND                                                               ND                              ND                                               Yes: *C. elegans*, BALB/c (i.n.) No: BALB/c (i.p.)                                                       Essex-Lopresti et al. ([@B42]), Boddey et al. ([@B13])
  *boaA*                                                           Adhesin                                                 DD503                               ↓: A549, Hep2                               Same as WT: J774A.1                           ND                                                          ND                                                     Same as WT: J774A.1                                              ND                              ND                                               ND                                                                                                       Balder et al. ([@B9])
  *boaB*                                                           Adhesin                                                 DD503                               ↓: A549, Hep2                               Same as WT: J774A.1                           ND                                                          ND                                                     Same as WT: J774A.1                                              ND                              ND                                               ND                                                                                                       Balder et al. ([@B9])
  *boaA/boaB*                                                      Adhesins                                                DD503                               ↓: A549, Hep2 (similar to single mutants)   Same as WT: J774A.1                           ND                                                          ND                                                     ↓ Growth: J774A.1 same as WT: epithelial cells                   ND                              ND                                               ND                                                                                                       Balder et al. ([@B9])
  **INVOLVED IN INVASION AND/OR ESCAPE FROM ENDOCYTIC VESICLES**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  *irlR*                                                           Two-component response regulator                        1026b                               ND                                          ↓: A549, HeLa, and CHO Not ↓ in macrophages   ND                                                          ND                                                     Same as WT: RAW                                                  ND                              ND                                               No: diabetic rats, hamsters (i.p.), and C57BL/6 (i.n.)                                                   Jones et al. ([@B66]), Wiersinga et al. ([@B140])
  *bopE*                                                           Bsa T3SS effector                                       10276 and DD503                     ND                                          Same as WT: J774.2 ↓: HeLa                    Same as WT: J774.2 (6 h p.i.)                               Yes: 6 h p.i.                                          Same as WT: J774.2                                               ND                              ND                                               No: BALB/c (i.n. and i.p.) and hamsters (i.p.)                                                           Stevens et al. ([@B120]), Stevens et al. ([@B117]), Stevens et al. ([@B119]), Warawa and Woods ([@B134])
  *bipD*                                                           Bsa T3SS translocator                                   10276 and 576                       ND                                          Same as WT: J774.2 and RAW 264.7 ↓: HeLa      ↓: J774.2 (6 h p.i) RAW264.7 (almost none up to 6 h p.i.)   No: J774.2 (6 h p.i.)                                  Almost no replication: J774.2                                    No                              Increased (RAW 264.7)                            Yes: BALB/c (i.n. and i.p.) and C57BL/6 IL-12 p40^−/−^ (i.p.)                                            Stevens et al. ([@B120]), Stevens et al. ([@B117]), Stevens et al. ([@B119]), Gong et al. ([@B50])
  *bsaQ*                                                           Bsa T3SS structural component                           K96243 and KHW                      ND                                          ↓: A549                                       Delayed: A549 (8 h p.i)                                     ND                                                     Same as WT: A549, J774A.1 and THP-1 (↓ killing of THP-1 cells)   Delayed: A549 (smaller MNGCs)   ND                                               ND                                                                                                       Sun et al. ([@B123]), Muangsombut et al. ([@B83])
  *bsaZ*                                                           Bsa T3SS structural component                           10276 and DD503                     ND                                          Same as WT: J774.2 and RAW 264.7              ↓: J774.2 (6 h p.i.) delayed: RAW 264.7 (18 h p.i.)         No: J774.2 (6 h p.i.) delayed: RAW 264.7 (12 h p.i.)   Almost no replication: J774.2 Can survive in RAW264.7            Delayed: RAW 264.7              ND                                               Yes: BALB/c (i.n.) and hamsters (i.p.)                                                                   Stevens et al. ([@B120]), Stevens et al. ([@B119]), Warawa and Woods ([@B134]), Burtnick et al. ([@B19])
  *sctU1/ sctU2/ bsaZ* triple                                      Bsa T3SS structural component of clusters 1, 2, and 3   DD503                               ND                                          Same as WT: RAW 264.7                         Same as *bsaZ* mutant                                       Delayed: RAW 264.7                                     Can survive in RAW264.7                                          Delayed: RAW 264.7              ND                                               Yes: hamsters (i.p.)                                                                                     Warawa and Woods ([@B134]), Burtnick et al. ([@B19])
  *bsaU*                                                           Bsa T3SS structural component                           E8                                  ND                                          Same as WT: HeLa                              Delayed: HeLa (12 h p.i.)                                   Delayed: HeLa                                          Same as WT: HeLa and J774A.1                                     ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *bopA*                                                           Bsa T3SS effector                                       K96243 and DD503                    ND                                          ↓: RAW 264.7                                  ↓: RAW 264.7                                                Delayed: RAW 264.7                                     ↓ Survival                                                       Yes (delayed) (RAW 264.7)       Increased co-localization with LC3 (RAW 264.7)   No: hamsters (i.p.) Mild: BALB/c (i.p.)                                                                  Stevens et al. ([@B119]), Warawa and Woods ([@B134]), Cullinane et al. ([@B28]), Gong et al. ([@B50])
  **INVOLVED IN INTRACELLULAR SURVIVAL**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  *purM*                                                           Phosphoribo syl-formyl-glycinamidine cyclo-ligase       E8                                  ND                                          Same as WT: HeLa                              ND                                                          Yes: HeLa                                              No replication: HeLa                                             ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *purN*                                                           Phosphorib osyl-glycinamide formyltransferase           E8                                  ND                                          Same as WT: HeLa                              ND                                                          Yes: HeLa                                              ↓ Replication: HeLa                                              ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *hisF*                                                           Imidazole glycerol phosphate synthase                   E8                                  ND                                          Same as WT: HeLa                              ND                                                          Yes: HeLa                                              ↓ Replication: HeLa                                              ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *pabB*                                                           *para*-aminobenzoate synthetase component               E8                                  ND                                          Same as WT: HeLa                              ND                                                          Yes: HeLa                                              ↓ Replication: HeLa                                              ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *bpsl1528*                                                       Putative exported protein                               E8                                  ND                                          Same as WT: HeLa                              ND                                                          Severely impaired: HeLa                                ↓ Replication: HeLa and J774A.1                                  ND                              ND                                               Yes: BALB/c (i.n.)                                                                                       Pilatz et al. ([@B93])
  *bpscN*                                                          T3SS-1 ATPase                                           K96243                              ND                                          Yes: RAW 264.7                                Same as WT: RAW 264.7                                       Same as WT: RAW 264.7                                  ↓ Survival: RAW 264.7                                            ND                              Increased co-localization with LC3 (RAW 264.7)   Yes: BALB/c (i.n.)                                                                                       D'Cruze et al. ([@B30])
  **INVOLVED IN ACTIN-BASED MOTILITY**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  *bimA*                                                           Autosecreted                                            10276                               ND                                          Yes: J774.2                                   Same as WT: J774.2                                          No: J774.2                                             Yes: J774.2                                                      No: J774.2                      Not susceptible (unpublished)                    ND                                                                                                       Stevens et al. ([@B115])
  **INVOLVED IN FORMATION OF MNGCS**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *rpoS*                                                           Global regulatory factor                                844                                 ND                                          \#x02193;: RAW 264.7                          Yes: RAW 264.7                                              ND                                                     Same as WT: RAW 264.7                                            ↓ MNGC                          ND                                               ND                                                                                                       Utaisincharoen et al. ([@B130])
  *bipB*                                                           Bsa T3SS translocator                                   K96243                              ND                                          ↓: HeLa and A549                              ND                                                          ND                                                     ND                                                               ↓: J774A.1                      ND                                               Yes: BALB/c (i.n.)                                                                                       Suparak et al. ([@B124])
  *hcp1*                                                           T6SS-1 component                                        K96243                              ND                                          Same as WT: RAW 264.7                         Yes: RAW 264.7                                              Yes: RAW 264.7 (slightly ↓)                            Delayed growth: RAW 264.7                                        No: RAW 264.7 (18 h p.i)        ND                                               Yes: hamsters (i.p.)                                                                                     Burtnick et al. ([@B18])
  **OTHERS**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  *lfpA*                                                           Lactonase family protein A                              DD503                               ND                                          ND                                            ND                                                          ND                                                     Same as WT: RAW 264.7                                            Same as WT: RAW 264.7           ND                                               Yes: hamsters (i.p.) BALB/c (i.n.)                                                                       Boddey et al. ([@B12])
  Capsule (SR1015)                                                 Glycosyltran sferase                                    1026b                               Yes                                         ↑: A549 and HeLa                              ND                                                          ND                                                     Same as WT: HeLa, A549                                           Yes: A549                       ND                                               Yes: hamsters (i.p.)                                                                                     Reckseidler et al. ([@B99]), Phewkliang et al. ([@B92])
  *fliC*                                                           Flagellin structural component                          Δ*fliC*: KHW Tn*5*--*fliC*: 1026b   Yes: A549                                   Same as WT: A549                              ND                                                          ND                                                     Same as WT: A549                                                 ND                              ND                                               Δ*fliC:* Yes: BALB/c (i.n. and i.p.) No: *C. elegans* Tn*5*--*fliC*: No: diabetic rats/hamsters (i.p.)   DeShazer et al. ([@B33]), Chua et al. ([@B23])

*ND, not determined; WT, wild-type; i.n., intranasal infection route; i.p., intraperitoneal infection route; ↓, reduced; ↑, increased*.

Type 4 fimbriae (pili) are known to be involved in the adhesion of a large number of bacterial species to a range of cell types, tissues, and other surfaces (Pelicic, [@B91]). Consequently, these hair-like filaments, or their individual protein components, frequently constitute key adhesins that may be necessary for virulence. In common with many Gram-negative species, *B. pseudomallei*, produces Type 4 pili. Inactivation of the *pilA* gene, which encodes the pilin subunit protein, abrogated the production of pili and resulted in reduced adhesion of *B. pseudomallei* to three different human epithelial cell lines, including A549 cells (Essex-Lopresti et al., [@B42]). Interestingly, adhesion to A549 and BEAS2-B cells was almost completely abolished, consistent with pili being a major bacterial adhesin, whereas adhesion of the *pilA* mutant to RPMI-2650 cells was approximately 30% that of the wild-type, suggesting the presence of additional adhesins (Table [1](#T1){ref-type="table"}). The basis for these differences remains unknown. The *pilA* gene can be regulated in response to temperature, with up-regulation at lower temperatures (27--30°C). However, a *pilA* *B. pseudomallei* mutant showed reduced adhesion to ME-180 cells derived from human cervical tissue (Table [1](#T1){ref-type="table"}). Interestingly, PilA does not mediate direct adherence of *B. pseudomallei* strain 08 to eukaryotic cells. Rather, up-regulation of *pilA* at lower temperatures is responsible for the formation of *B. pseudomallei* microcolonies. These microcolonies in turn display a higher level of adherence to eukaryotic cells (Boddey et al., [@B13]). However, temperature regulation was not observed in strain K96243, the first strain to have its genome sequenced. Adhesion to six different human epithelial cell lines by strain 08 was also enhanced at 30°C, but the role of pili was not investigated (Brown et al., [@B17]). These studies again highlight the need for caution in extrapolating data derived with different *B. pseudomallei* strains and different eukaryotic cell lines.

Flagellum-mediated adhesion was a prerequisite for invasion of the free-living ameba *Acanthamoeba astronyxis* (Inglis et al., [@B61]). However, a defined aflagellar *fliC* mutant was markedly attenuated in BALB/c mice, but was unimpaired in its ability to invade A549 cells (Chua et al., [@B23]; Table [1](#T1){ref-type="table"}). These findings suggest that flagellae are required for virulence in mice, but probably do not constitute a major adhesin for mammalian cells.

A recent study identified two novel adhesins in *B. pseudomallei* (Balder et al., [@B9]). The BoaA protein shares similarity with the YadA autotransporter adhesin of *Yersinia enterocolitica* and is present also in *B. mallei*. Recombinant BoaA expressed in *E. coli* enhanced the adhesion of *E. coli* to A549 and Hep2 cells, while inactivation of the *boaA* gene reduced, but did not abolish, adhesion of *B. pseudomallei* to both cell lines (Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}). A second related gene, *boaB*, appears to be unique to *B. pseudomallei*. Expression of BoaB in *E. coli* also increased adhesion to A549 and Hep2 cells and mutation of *boaB* reduced adhesion to epithelial cell lines (Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}). Significantly, a similar phenotype was observed with cultured normal human bronchial epithelium. A double *boaA*/*boaB* mutant exhibited levels of adhesion similar to those of either single mutant, with some residual binding remaining (Table [1](#T1){ref-type="table"}). These findings suggest that multiple adhesins are involved in the adhesion of *B. pseudomallei* to eukaryotic cells. Moreover, different adhesins may be involved in the interaction of bacteria with different cell types.

Intracellular Invasion, Escape from Endocytic Vesicles, and Survival within the Cytoplasm
=========================================================================================

It is likewise a widely accepted notion that initial adherence of pathogenic bacteria to the external surface of host cells is followed immediately by intracellular invasion. Over the last decade, the pace of research addressing how *B. pseudomallei* gains access to the intracellular environment and how it subsequently escapes from endocytic vesicles into the cytoplasm has accelerated, providing much needed insight into this critical step of pathogenesis. Despite this knowledge, a comprehensive understanding of the precise mechanism of intracellular invasion and subsequent endosomal escape is still lacking.

Entry into host cells
---------------------

*Burkholderia pseudomallei* is taken up by phagocytic cells such as polymorphonuclear leukocytes (Pruksachartvuthi et al., [@B94]; Egan and Gordon, [@B38]; Jones et al., [@B65]) and macrophages (Pruksachartvuthi et al., [@B94]; Harley et al., [@B58], [@B57]; Jones et al., [@B65]; Kespichayawattana et al., [@B70]; Utaisincharoen et al., [@B132]) and can invade non-phagocytic cell lines such as HeLa, CHO, A549, and Vero cultured epithelial cell lines (Jones et al., [@B65]; Harley et al., [@B56]; Kespichayawattana et al., [@B70]). The invasiveness of *B. pseudomallei* and its avirulent counterpart, *B. thailandensis*, was compared in the human respiratory epithelial cell line A549; the invasive capacity of *B. pseudomallei* was significantly greater than that of *B. thailandensis* (Kespichayawattana et al., [@B69]).

A *B. pseudomallei* 1026b transposon mutagenesis screen identified a gene encoding a putative two-component response regulator that is involved in the invasion of the epithelial cell line A549, HeLa, and CHO cells, but not macrophages (Jones et al., [@B66]; Figure [1](#F1){ref-type="fig"}). The transposon mutant exhibited an invasion level only 10% that of the parental strain, 1026b, in epithelial cells. The disrupted two-component response regulator was therefore named *irlR* for invasion-related locus (Table [1](#T1){ref-type="table"}). A putative two-component sensor, *irlS*, was located downstream of the response regulator. This *irlRS* two-component regulatory system is not involved in virulence, as the mutant remained virulent in diabetic rats, hamsters (Jones et al., [@B66]), and C57BL/6 mice (Wiersinga et al., [@B140]), suggesting that the tissue culture invasion defect observed *in vitro* was not related to pathogenesis *in vivo*.

Many diverse Gram-negative pathogenic bacteria use Type 3 Secretion Systems (T3SS) as a conserved, but highly adapted, virulence mechanism. The T3SS apparatus comprises approximately 20 different proteins assembled into a syringe-like structure that spans the bacterial inner and outer membranes, enabling the bacteria to secrete and inject effector molecules into the cytosol of eukaryotic host cells for the subversion of cellular functions (Hueck, [@B59]; Zhang et al., [@B145]; Sun and Gan, [@B122]). Although the components of the T3SS apparatus are conserved between species, the secreted proteins are highly divergent (Hueck, [@B59]). *B. pseudomallei* encodes three T3SS clusters. Clusters 1 and 2 are similar to the T3SS gene clusters encoding the Hrp secretons of the plant pathogens *Ralstonia* (formerly *Burkholderia*) *solanacearum* and *Xanthomonas* spp. (Winstanley et al., [@B141]; Rainbow et al., [@B97]). However, cluster 3 shares homology to the *inv/spa/prg* T3SS of *Salmonella* Typhimurium and the *ipa/mxi/spa* T3SS of *Shigella flexneri* (Attree and Attree, [@B7]; Stevens et al., [@B116]; Rainbow et al., [@B97]) and has been designated the *Burkholderia* secretion apparatus (*bsa*) T3SS (Stevens et al., [@B120]).

Numerous studies have demonstrated the importance of the Bsa T3SS in the intracellular survival, replication, and virulence of *B. pseudomallei*. Indeed, numerous structural components (BsaQ, BsaU, and BsaZ), translocator (BipD), and effector proteins (BopA and BopE) of the Bsa T3SS have been implicated in various aspects of the intracellular lifecycle of *B. pseudomallei*, including invasion of host cells, escape from endocytic vesicles, and intracellular survival. Studies have shown that the invasion event requires the proteins BopE, BipD (Stevens et al., [@B117]), and BsaQ (Muangsombut et al., [@B83]; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}). BopE shares similarity with the *Salmonella* SopE/SopE2 effector proteins which act as guanine nucleotide exchange factors (GEFs) for RhoGTPases that regulate the actin network (Hardt et al., [@B55]; Rudolph et al., [@B100]; Stender et al., [@B112]) and in turn facilitate bacterial invasion (Wood et al., [@B143]; Bakshi et al., [@B8]). Likewise, BopE facilitates bacterial invasion of non-phagocytic cells, as a *B. pseudomallei* 10276 *bopE* mutant displayed a significant reduction in invasion of HeLa cells when compared to the wild-type strain (Stevens et al., [@B117]). In turn, BopE induces rearrangements in the subcortical actin cytoskeleton and also exhibits GEF activity. It was concluded that in epithelial cells, BopE is likely to be translocated into the host cell cytosol, where it may facilitate membrane ruffling by acting as a GEF for Cdc42 and Rac1 (Stevens et al., [@B117]). This notion is supported by a subsequent study by Upadhyay et al. ([@B127]) which showed that BopE and SopE/SopE2 catalytic domains adopt similar three-dimensional folds, but that BopE has a more compact conformation. An interaction of the catalytic domain of BopE~78--261~ with Cdc42 was also demonstrated. Interestingly, the SopE residues involved in contacting Cdc42 and the residues that were shown by mutation to be functionally important in SopE are conserved or conservatively substituted in BopE. Taken together, these data suggest that BopE uses the same mechanism as SopE and other Rho GEFs in catalyzing guanine nucleotide exchange in Rho GTPases, despite the fact that BopE possesses a more closed conformation (Upadhyay et al., [@B127]). The study performed by Stevens et al. ([@B117]) also provided evidence that BipD, a translocator protein located on the tip of the needle (Johnson et al., [@B64]) and similar to *Salmonella* SipD, is also involved in invasion of non-phagocytic cells, as a 10276 *bipD* mutant was impaired in invasion of HeLa cells and notably, to an even greater extent than the *bopE* mutant described above, implying that several Bsa proteins may act in concert with BopE to facilitate bacterial invasion (Stevens et al., [@B117]; Stevens and Galyov, [@B118]).

BsaQ shares a high degree of identity with *Salmonella* Typhimurium InvA (56%; Ginocchio and Galán, [@B46]) and therefore by analogy, BsaQ is most likely to be a conserved inner-membrane channel protein, located at the base of the T3SS apparatus (Muangsombut et al., [@B83]). A *B. pseudomallei* K96243 *bsaQ* mutant exhibited a 30% reduction in invasion of A549 cells when compared to wild-type *B. pseudomallei* (Muangsombut et al., [@B83]). In turn, mutation of the *bsaQ* (Bsa structural component) gene prevented the secretion of at least two T3SS proteins, BopE and BipD (Muangsombut et al., [@B83]). Taken together, as it has been shown that BopE and BipD are required for invasion of non-phagocytic cells (Stevens et al., [@B117]), it can be speculated that the impaired invasion efficiency exhibited by the *bsaQ* mutant is a consequence of its inability to secrete the effector protein BopE and the translocator BipD. Interestingly, BopE and BipD do not appear to play a role in invasion of phagocytic cells, namely J774.2 murine macrophage-like cells, as *bopE* and *bipD* mutants were taken up by J774.2 cells in comparable numbers to the wild-type strain *B. pseudomallei* 10276 (Stevens et al., [@B120]). Likewise, we have shown that BipD is not necessary for invasion of RAW 264.7 macrophage-like cells (Gong et al., [@B50]; Table [1](#T1){ref-type="table"}). These data indicate the importance of different T3SS mechanisms for the invasion of non-phagocytic and phagocytic cells.

Escape from endocytic vesicles
------------------------------

Once a bacterium gains access to the intracellular environment, it must rapidly invoke strategies to survive within this niche. Accordingly, within 15 min of internalization, *B. pseudomallei* strain 708a can escape from endocytic vesicles into the cytoplasm of RAW 264.7, HeLa, and human macrophage-like U937 cells (MOI of either 1000:1 or 100:1) by lysing endosome membranes thus avoiding degradation through the lysosomal system (Harley et al., [@B57]). Several Bsa T3SS proteins play a role in escape of *B. pseudomallei* from endocytic vesicles.

We have recently shown that the putative Bsa T3SS effector protein BopA plays an important role in escape of *B. pseudomallei* from phagosomes (Cullinane et al., [@B28]; Gong et al., [@B50]); a *bopA* mutant displayed reduced intracellular survival and significantly increased co-localization with GFP--LC3 in RAW 264.7 cells when compared to cells infected with wild-type K96243 (Table [1](#T1){ref-type="table"}), indicating the decreased ability of the mutant to escape from the phagosome (Cullinane et al., [@B28]). The same mutant showed reduced phagosomal escape compared to wild-type when analyzed by transmission electron microscopy (TEM); mutant bacteria that were free in the cytoplasm however, could form actin-tails and stimulate MNGC formation (Gong et al., [@B50]). These data indicate that BopA is important for efficient escape from phagosomes (Figure [1](#F1){ref-type="fig"}). However, the mechanism by which BopA modulates phagosomal escape is not known. Two possible functional domains have been identified in BopA that may contribute to its function in phagosomal escape. The first is a carboxy-terminal Rho GTPase inactivation domain (RID) which may function as a protease or acyltransferase acting on host molecules (Pei and Grishin, [@B90]). The second is a cholesterol binding domain (CBD; Kayath et al., [@B68]). In macrophages infected with *Mycobacterium avium*, cholesterol depletion triggered phagolysosomal or autophagolysosomal formation with consequent bacterial degradation (de Chastellier and Thilo, [@B31]). Similarly, the binding of cholesterol by BopA may lead to the accumulation of cholesterol on phagosome membranes, thereby limiting lysosomal recognition and/or fusion. The function of both domains is amenable to testing. Notably, BopA from *B. mallei* is important for invasion and intracellular survival within J774A.1 macrophage cells; a *B. mallei* *bopA* mutant showed reduced phagocytic uptake and reduced intracellular survival (Whitlock et al., [@B138]). In murine alveolar macrophage (MH-S) cells, a *B. mallei* *bopA* mutant was recovered at higher levels from intracellular compartments compared to wild-type *B. mallei*, suggesting that the *bopA* mutant remains within intracellular compartments longer than wild-type, resulting in decreased escape (Whitlock et al., [@B139]).

BsaZ, similar to *Salmonella* SpaS, is the last gene in the *bsa* gene cluster that encodes a structural component of the T3SS apparatus (Stevens et al., [@B120]). By examining the association of intracellular bacteria with lysosome-associated membrane glycoprotein-1 (LAMP-1) containing vacuoles, it has been shown that *bsaZ* and *bipD* mutants are highly delayed in their ability to escape from endocytic vesicles; 95.1 and 95.9% of *bsaZ* and *bipD* mutant bacteria respectively were LAMP-1 associated in J774.2 cells at 6 h post-infection (p.i.; Stevens et al., [@B120]). Similarly, in analyses using TEM, the *bsaZ* mutant was consistently observed only within vesicles with fully intact membranes (Stevens et al., [@B120]) and only 2% of *bipD* mutants were able to escape into the cytoplasm of RAW 264.7 cells by 6 h p.i. (Gong et al., [@B50]; Table [1](#T1){ref-type="table"}). A similar study performed by Burtnick et al. ([@B19]) also showed a phagosome escape defect for a *bsaZ* mutant in activated RAW 264.7 murine macrophage-like cells. Using TEM analyses they demonstrated that in concordance with results outlined by Stevens et al. ([@B120]) at 6 h p.i., the *bsaZ* mutant remained in endocytic vesicles; however, by 12 h p.i. bacteria had begun to escape and by 18 h p.i. the majority of mutant bacteria were located in the cytoplasm (Burtnick et al., [@B19]). Thus, the *bsaZ* mutant does retain the ability to escape from endocytic vesicles, but this process is delayed by 6 to 12 h compared to the parent strain, DD503 (Burtnick et al., [@B19]; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}).

In non-phagocytic A549 cells, a *bsaQ* mutant also showed delayed escape from endocytic vesicles with 59.4% of mutant bacteria co-localizing with LAMP-1 positive vacuoles at 6 h p.i.; at 8 h p.i. further escape from vacuoles was observed (Muangsombut et al., [@B83]; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}). Likewise, a transposon mutant which disrupted the gene *bsaU* (Bsa structural component), which is thought to control needle length and whose product shares ∼20% similarity with Spa32 (Sun and Gan, [@B122]), was unable to escape from endocytic vesicles 6 h after infection of HeLa cells (Pilatz et al., [@B93]). The mutant however, retained the ability to multiply within the vacuoles, resulting in the formation of large vesicles containing many bacteria; at 12 h p.i. mutant bacteria began to escape, indicating a delayed escape phenotype for this mutant (Pilatz et al., [@B93]; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}).

The delayed escape phenotype observed for several Bsa T3SS mutants suggests that mechanisms other than the Bsa T3SS may be involved in escape from endocytic vesicles. It is noteworthy to consider the possibility of "cross-talk" taking place between the three T3SS clusters in *B. pseudomallei*. Interestingly, a triple mutant with stable deletions in the genes *sctU1*, *sctU2*, and *bsaZ*, which all encode the putative major inner-membrane subunits of T3SS clusters 1, 2, and 3 of *B. pseudomallei*, respectively, exhibited the same delayed escape phenotype as the *bsaZ* mutant described above (Burtnick et al., [@B19]; Table [1](#T1){ref-type="table"}). This therefore provides evidence that components of the T3SS-1 and T3SS-2 are not responsible for the delayed escape phenotype observed for the *bsaZ* mutant and that other factors are involved in delayed phagosomal escape in RAW 264.7 cells (Burtnick et al., [@B19]). However, we have recently shown that the T3SS cluster 1 predicted ATPase encoded by *bpscN* is essential for full virulence of *B. pseudomallei* in a BALB/c mouse infection model (D'Cruze et al., [@B30]). A *bpscN* mutant was highly attenuated for virulence in BALB/c mice, displayed reduced intracellular replication in RAW 264.7 macrophage-like cells and increased co-localization with the autophagy marker protein LC3, but was unimpaired for escape from phagosomes. Thus, the T3SS cluster 1 does play a role in the intracellular survival of *B. pseudomallei*.

Intracellular survival
----------------------

Subsequent to invasion and escape from endocytic vesicles, the ability of *B. pseudomallei* to survive intracellularly is important for progression of infection. Screening of transposon mutants by Pilatz et al. ([@B93]) identified nine mutants with reduced ability to form plaques on PtK2 cell monolayers, indicating a reduced capacity for intercellular spreading. Inactivation of *bsaU* and its role in escape from endocytic vesicles has been discussed earlier in this review. In addition to *bsaU*, Pilatz et al. ([@B93]) showed that purine (*purM* and *purN*), histidine (*hisF*), and *para*-aminobenzoate (*pabB*) biosynthetic pathway genes and *bpsl1528* are all important for intracellular replication and survival.

Neither *purM*, encoding a putative phosphoribosyl-formyl-glycinamidine cyclo-ligase, nor *purN*, encoding a putative phosphoribosylglycinamide formyltransferase, were required for invasion of HeLa cells; both mutants displayed wild-type levels of cellular invasion. However, both purine biosynthesis pathway mutants were defective for intracellular growth. Interestingly, the *purM* mutant showed no intracellular replication during the course of the experiment. Similarly, *hisF* (encoding a putative imidazole glycerol phosphate synthase) and *pabB* (encoding a putative *para*-aminobenzoate synthetase component) mutants also retained the ability to invade HeLa cells, but were impaired for intracellular growth. Although intracellular growth was impaired for *purM*, *purN*, *hisF*, and *pabB* mutants, actin-tail formation, and the ability to form membrane protrusions were not affected. These findings contrast with those for a *bpsl1528* mutant (encoding a putative exported protein) that not only displayed severely restricted intracellular growth in HeLa and J774A.1 macrophages, but was also defective in formation of actin-tails and membrane protrusions.

Relevance for *in vivo* pathogenesis
------------------------------------

While studies focusing on intracellular invasion, escape from endocytic vesicles and subsequent intracellular replication and survival using various defined mutants have provided insight into the pathogenesis of *B. pseudomallei* in an *in vitro* setting, it is critical to understand the role of the corresponding gene products for *in vivo* pathogenesis. Numerous virulence studies have been carried out and it appears that, with the exception of the *bopE* (effector) mutant, a correlation exists between the *in vitro* invasion and escape defects observed for various Bsa T3SS structural component and translocator mutants, and their reduced ability to cause disease. The *bsaU* transposon mutant, *bsaZ* and *bipD* mutants described above were all attenuated in BALB/c mice following intranasal infection (Stevens et al., [@B119]; Pilatz et al., [@B93]). The *bipD* mutant was also attenuated following intraperitoneal infection and this correlated with reduced bacterial replication in the liver and spleen (Stevens et al., [@B119]), suggesting a role for BipD during both systemic and mucosal infection. A *bsaZ* triple mutant (with deletions in the *bsaZ* homologs, *sctU*, in clusters 1 and 2 as described above) was significantly attenuated in hamsters; however, double and single mutants in *sctU* of clusters 1 and 2 that did not share the cluster 3 *bsaZ* mutation were not attenuated (Warawa and Woods, [@B134]). However, a T3SS cluster 1 *bpscN* mutant was attenuated in BALB/c mice (D'Cruze et al., [@B30]). Taken together, these virulence data indicate that a functional Bsa T3SS apparatus is required for full virulence of *B. pseudomallei*. Further, BipD and therefore the Bsa T3SS, is functionally expressed during infection *in vivo*, as antibodies against BipD have been detected in convalescent melioidosis patient sera (Stevens et al., [@B120]; Allwood et al., [@B3]).

Interestingly, the *bopE* mutant was not attenuated in BALB/c mice following either intraperitoneal or intranasal infection (Stevens et al., [@B119]), indicating that the effector protein BopE, on its own, is not essential for virulence and that other effectors must play a role in subversion of normal cellular processes during both systemic and mucosal infection. In turn, Warawa and Woods ([@B134]) also demonstrated that a *bopE* mutant and other putative effector mutants (*bopA*, *bapA*, and *bapC*) were not attenuated for virulence in the acute hamster model. However, a *bopA* mutant showed a mild attenuation in the BALB/c mouse model (Stevens et al., [@B119]). It has been theorized that the *B. pseudomallei* Bsa T3SS functions by delivering a set of effector proteins that target specific host cell pathways and that each individual effector alone may actually contribute little to virulence; however, the contribution of multiple effector proteins working in a cooperative manner may have a significant pathogenic impact (Galyov et al., [@B45]). As such, the generation of double and/or triple effector mutants would address this issue.

Similarly, a correlation also exists between the ability to replicate intracellularly and the ability to cause disease. All mutants identified by Pilatz et al. ([@B93]) that were defective for intracellular growth (*purM, purN, hisF, pabB*, and *bpsl1528*) were also attenuated for virulence in BALB/c mice following intranasal infection. Interestingly, in the case of the *purM*, *pabB*, and *bpsl1528* mutants, all animals not only survived following challenge with 10^7^ CFU, but also showed no signs of disease (Pilatz et al., [@B93]). This study therefore highlights the important role that the purine, histidine and *para*-aminobenzoate biosynthetic pathways and *bpsl1528* play in pathogenesis.

Taken together, these data indicate the importance of numerous genes and proteins involved in the intracellular life cycle of *B. pseudomallei*, including those involved in T3SS and various biosynthetic pathways. Importantly, the requirement for a functional T3SS with the ability to secrete effector proteins is vital for pathogenesis. Clearly, the secretion of numerous effector proteins that function in a collaborative manner, rather than individually, is critical for effective subversion of host cellular functions and therefore for pathogenesis.

Actin-Based Motility: A Crucial Mechanism for Cell-to-Cell Spread
=================================================================

Members of several genera, including *Burkholderia*, *Listeria*, *Shigella*, *Rickettsia*, and *Mycobacterium*, have the remarkable ability to propel themselves through the cytoplasm by polymerization of the eukaryotic cytoskeletal protein actin at the surface of one pole of the bacterium. The force generated by this actin-based motility propels the bacterium through the cytoplasm, at speeds that range from 3 to 87 μm/min, depending on the pathogen and the cell type (Stevens et al., [@B113]). This motility facilitates the formation of membrane protrusions into neighboring cells and concomitant cell-to-cell spread (Gouin et al., [@B53]; Stevens et al., [@B113]). Since the late 1980s, an abundance of research has furthered the understanding of how such intracellular pathogens manipulate the host actin polymerization machinery for their benefit. Ultimately, actin-based motility facilitates the avoidance of host innate and adaptive immune responses as the pathogen spreads directly from cell-to-cell.

The Arp2/3 complex
------------------

The majority of pathogens capable of actin-based motility do so by exploiting the Arp2/3 complex. This conserved host protein complex consists of seven polypeptides and is involved in both actin filament nucleation and organization (Cossart, [@B26]). On its own, the Arp2/3 complex possesses weak biochemical activity. The complex becomes activated by nucleation promoting factors (NPFs), which include members of the Wiskott--Aldrich syndrome protein (WASP) family; this activation leads to a conformational change in the complex (Welch and Mullins, [@B136]; Goley et al., [@B48]; Gouin et al., [@B53]; Goley and Welch, [@B49]). This change initiates the formation of a new filament that emerges from an existing filament, generating a y-branched actin network (Mullins et al., [@B84]; Amann and Pollard, [@B4]; Goley and Welch, [@B49]). Intracellular bacteria have developed a number of different mechanisms for activating the Arp2/3 complex, thereby exploiting the complex for their own benefit. Research to date has identified two main strategies. These mechanisms include either the expression of mimics of the WASP family NPFs (e.g., *Listeria monocytogenes* ActA/*Listeria ivanovii* IactA, or *Rickettsia* RickA), or surface proteins that function by recruiting host family WASP (N-WASP) proteins (e.g., *S. flexneri* IcsA; Welch et al., [@B135], [@B137]; Egile et al., [@B39]; May et al., [@B81]; Boujemaa-Paterski et al., [@B14]; Gouin et al., [@B52], [@B53]; Jeng et al., [@B63]). The expression of the bacterial protein, predominately at one pole of the cell, therefore initiates actin polymerization by direct or indirect activation of the Arp2/3 complex at the surface of the pathogen (Stevens et al., [@B115]).

BimA and its role in actin-based motility
-----------------------------------------

Interestingly, it seems that *B. pseudomallei* employs a unique mechanism for activation of actin-based motility. Initial evidence that demonstrated the ability of *B. pseudomallei* to induce cellular actin rearrangement and membrane protrusions in both phagocytic and non-phagocytic cells was provided by Kespichayawattana et al. ([@B70]). Actin rearrangement in a "comet" tail formation, typical of actin-based motility, was observed at one pole of the bacterium after staining *B. pseudomallei*-infected J774A.1 and HeLa cells with rhodamine-conjugated phalloidin. It was later discovered that actin-based motility of *B. pseudomallei* is dependent upon the autosecreted protein, BimA (Stevens et al., [@B115]). Mutation of *bimA* abolished actin-based motility of *B. pseudomallei*; importantly however, the mutation did not influence the activity of the Bsa T3SS and the mutant retained the ability to escape from endosomes (Stevens et al., [@B115]; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}). Evidence supporting the notion that actin-based motility is a prerequisite for intercellular spread was provided by Stevens et al. ([@B115]) and Sitthidet et al. ([@B110]). A *bimA* mutant did not form membrane protrusions in J774.2 cells (Stevens et al., [@B115]) and did not form plaques in A549 monolayers (Sitthidet et al., [@B110]), indicating the *bimA* mutant could not spread from cell-to-cell. Reminiscent of ActA and IcsA, BimA was found to localize at one pole of the bacterial cell where actin assembly takes place (Stevens et al., [@B115]). Interestingly, BimA homologs in *B. mallei* and *B. thailandensis* (which also possess the ability to induce actin-based motility in J774.2 cells) can restore the actin-based motility defect of a *B. pseudomallei* *bimA* mutant (Stevens et al., [@B114]).

A survey of the prevalence and sequence diversity of BimA in clinical and environmental isolates from endemic areas demonstrated intraspecies conservation of BimA in natural populations of *B. pseudomallei*, *B. mallei*, and *B. thailandensis* (Sitthidet et al., [@B111]). In addition, tandem WASP homology 2 (WH2) domains, which are predicted to mediate the binding of actin monomers, were conserved in sequenced *B. pseudomallei* strains (Sitthidet et al., [@B111]). These domains were later found to be required for actin binding, actin assembly, and therefore, actin-based motility (Sitthidet et al., [@B110]). A proline-rich motif (IP~7~, also known as PRM1) which is known to interact with profilin and functions to funnel actin monomers to the tip of actin filaments, was also conserved in sequenced *B. pseudomallei* strains. In addition, a tandem repeat of 13 amino acids adjacent to the IP~7~ motif on the amino-terminal side (NIPVPPPMPGGGA) was conserved in most sequenced *B. pseudomallei* strains (Sitthidet et al., [@B111]). However, later studies indicated that the 13 amino acid repeat and the IP~7~ proline-rich motif are not essential for actin-based motility *in vitro* (Sitthidet et al., [@B110]). The number of PDASX repeats that are adjacent to the WH2 domains on the carboxyl-terminal side was also found to vary within sequenced *B. pseudomallei* strains, with the number of repeats ranging from 2, 5 to 7 copies (Sitthidet et al., [@B111]). It was demonstrated that a tract of five PDASX direct repeats was required for actin-based motility and intercellular spread; however, they were not involved in actin binding. Interestingly, the rate of polymerization increased in a stepwise manner as the number of PDASX repeats increased from zero to two to five to seven, indicating that these repeats act in an additive manner to stimulate polymerization of pyrene-actin monomers *in vitro* (Sitthidet et al., [@B110]).

*Burkholderia pseudomallei* employs a unique mechanism for activation of actin-based motility
---------------------------------------------------------------------------------------------

*Burkholderia pseudomallei* does not activate actin-based motility via a *Shigella*-like mechanism, as N-WASP is not found on either the surface of *B. pseudomallei* or within actin-tails (Breitbach et al., [@B15]). This, and the fact that F-actin clustering results from transient expression of BimA, a characteristic that is seen with WASP overexpression (Stevens et al., [@B115]), indicate that BimA may function as an NPF mimic to induce actin-based motility in infected cells (Stevens et al., [@B113]). However, the mechanism appears distinct from that of *Listeria*, as VASP proteins were not detected on the surface of *B. pseudomallei* and only very weakly throughout actin-tails (Breitbach et al., [@B15]); this is in contrast to *Listeria* where Ena/VASP proteins interact directly with ActA (Laurent et al., [@B75]). Confirmatory to these results, infection of N-WASP- or Ena/VASP-defective cells with *B. pseudomallei* demonstrated that these proteins are not essential for actin-based motility by *B. pseudomallei* (Breitbach et al., [@B15]).

Interestingly, while the Arp2/3 complex is strongly incorporated into *B. pseudomallei* actin-tails (Breitbach et al., [@B15]), its precise function in actin polymerization is not clear. BimA can stimulate actin polymerization *in vitro* in an Arp2/3 independent manner (Stevens et al., [@B115]). In addition, overexpression of an Arp2/3 binding WCA (WH2, central, and acidic) domain of Scar1 (NPF), which leads to cytoplasmic sequestration and inhibition of the Arp2/3 complex, and therefore inhibition of motility of *Listeria*, *Shigella*, and *Rickettsia conorii*, had no effect on actin-based motility of *B. pseudomallei* (Breitbach et al., [@B15]). Based on these data, it appears that the mechanism of actin-based motility of *B. pseudomallei* is distinct from that identified for all other intracellular pathogens studied to date. It has been suggested that BimA alone may be sufficient for intracellular motility of *B. pseudomallei*; however, the requirement for other bacterial co-factors or different post-translational modifications of BimA cannot be ruled out (Stevens et al., [@B113]).

A potential role for type VI secretion system cluster 1 and other gene products in actin-based motility
-------------------------------------------------------------------------------------------------------

The *B. pseudomallei* genome encodes six functional Type 6 Secretion Systems originally designated T6SS-1-6 (Schell et al., [@B104]). A subsequent paper by Shalom et al. ([@B108]) however, assigned the names *tss-5*, *tss-4*, *tss-6*, *tss-3*, *tss-2*, and *tss-1*, respectively, to these same gene clusters. As such, we will refer to the nomenclature used by Schell et al. ([@B104]).

T6SS play a role in virulence in many bacterial pathogens where they function to inject effector proteins into host cells (Pukatzki et al., [@B96]). New evidence has demonstrated that in *B. mallei*, the T6SS-1 plays an important role in actin-based motility in RAW 264.7 cells; *tssE* mutants were able to undergo vacuolar escape, but once in the cytoplasm the mutants exhibited defects in actin polymerization and intra- and intercellular spread (Burtnick et al., [@B20]). Importantly, a homologous T6SS expressed in *B. pseudomallei* is similarly induced following uptake by RAW 264.7 cells. This system (T6SS-1; locus tags BPSS1493--BPSS1511) is flanked by *bimA* on one side and the Bsa T3SS locus on the other (Shalom et al., [@B108]). By analogy with *B. mallei*, it could be speculated that mutation of T6SS-1 in *B. pseudomallei* would also cause actin polymerization defects and raises the question as to whether secreted effectors of the T6SS, such as Hcp and/or VgrG, could interact with BimA. Importantly however, a T6SS-1 *tssH* mutant showed no difference in invasion and survival within RAW 264.7 cells compared to wild-type *B. pseudomallei*; its ability to polymerize actin and undergo actin-based motility was not investigated (Shalom et al., [@B108]). A subsequent study by Burtnick et al. ([@B18]) has now shown that while a *hcp1* (from T6SS-1) mutant did demonstrate a slightly reduced level of actin-based motility compared to wild-type *B. pseudomallei*, this difference was not as significant as that observed in the *B. mallei* *tssE* T6SS-1 mutant described above (Burtnick et al., [@B20]). *tssE* is predicted to encode a component of the T6SS-1 apparatus and appears to be required for Hcp1 secretion (Schell et al., [@B104]). Therefore, it appears likely that *tssE* is required for secretion of other effector(s) that may play a role in actin polymerization, as mutation of *hcp1* on its own had little effect on actin-based motility. Interestingly however, mutation of *hcp1* resulted in the absence of MNGC formation (discussed elsewhere in this review), delayed intracellular growth, and reduced cytotoxicity in RAW 264.7 cells (Burtnick et al., [@B18]).

Another gene which has been implicated for its potential role in actin-tail formation is *bpsl1528* which encodes a putative exported protein (Pilatz et al., [@B93]). As described above, a *bpsl1528* mutant was defective for intracellular growth; immunofluorescence microscopy revealed that actin-tail formation was severely impaired as only rudimentary actin-tails were observed and no protrusions could be detected in HeLa cells. However, the mutant also demonstrated reduced swimming motility. Pilatz et al. ([@B93]) therefore speculated that the pleiotropic phenotype of the *bpsl1528* mutant may be due to a regulatory function of the encoded protein on numerous virulence factors rather than to a single effector molecule.

In summary, the role of BimA in actin-based motility is widely accepted. However, further evidence has indicated that the process of actin polymerization leading to actin-based motility may occur as a result of a concerted effort involving other bacterial factor(s) that could involve the T6SS cluster 1 and other putative exported proteins. Interestingly, the process of activation of actin-based motility by *B. pseudomallei* is distinct from that observed for other pathogens and further studies are therefore required to address this issue.

Cell Fusion and the Formation of Multi-Nucleated Giant Cells: Important Mechanisms for the Progression of Infection
===================================================================================================================

As outlined above, several species of intracellular pathogens are able to move throughout the cell cytoplasm by manipulating actin polymerization. For *Shigella*, actin-based motility is also sufficient for the movement of bacteria from cell-to-cell via membrane protrusions (Monack and Theriot, [@B82]). Indeed, recombinant *E. coli* cells expressing *S. flexneri* IcsA (required for actin polymerization) were able to produce membrane protrusions in HeLa cells and move into the cytoplasm of adjacent cells (Monack and Theriot, [@B82]). While actin-based motility is an essential prerequisite for the spread of *B. pseudomallei* from cell-to-cell (Stevens et al., [@B115]; Sitthidet et al., [@B110]), cell fusion, and the production of MNGC also appears to be required. Infection of phagocytic or non-phagocytic cell lines with *B. pseudomallei*, *B. mallei*, or *B. thailandensis* results in cell-to-cell fusion and the formation of MNGC (Harley et al., [@B56]). Furthermore, MNGC have also been observed following histopathological assessment of human tissue samples recovered from melioidosis patients (Wong et al., [@B142]), suggesting that MNGC formation occurs during *B. pseudomallei* infection. Other infectious agents such as human immunodeficiency virus (HIV; Ciborowski and Gendelman, [@B24]), cytomegalovirus (CMV; Kinzler and Compton, [@B71]), herpes simplex virus (HSV; Cole and Grose, [@B25]), and mycobacterial species (Utermöhlen et al., [@B133]) also drive the formation of MNGC.

Induction of cell fusion following *B. pseudomallei* infection was confirmed by analysis of co-cultures of J774A.1 cells that had been labeled either with cell tracker green CMFDA or cell tracker red CMTMR prior to mixing (Kespichayawattana et al., [@B70]). Orange--yellow MNGC were observed within 4--6 h after infection, indicating that some of the eukaryotic cell membranes had fused; no fused cells were observed in mock infected cultures. Similar results were obtained with HeLa and L929 cells, although the rate of cell fusion and MNGC formation was slower. *B. pseudomallei* infection leads to apoptosis of both fused and unfused cells. At 2 h p.i. approximately 3% of cells showed evidence of apoptotic changes and this increased to 43% by 6 h. Interestingly, within MNGC, both normal nuclei and those showing apoptotic changes could be observed (Kespichayawattana et al., [@B70]).

The molecular mechanisms leading to cell fusion and formation of MNGC following *B. pseudomallei* infection are poorly characterized. Macrophage cell fusion may be associated with chronic inflammation and can be induced *in vitro* by treatment of macrophages with certain cytokines, including macrophage colony-stimulating factor, granulocyte--macrophage colony-stimulating factor, interleukin (IL)-4 and IFN-γ (Kondo et al., [@B73]). Cell fusion in response to infections with the viruses CMV and HSV is associated with the production of viral glycoproteins (Cole and Grose, [@B25]; Kinzler and Compton, [@B71]). In *B. pseudomallei*, the ability to form MNGC has been associated with RpoS, BipB, T6SS-1, and the putative toxin-encoding genes *bpsl0590* and *bpsl0591* (Figure [1](#F1){ref-type="fig"}).

A *B. pseudomallei* *rpoS* mutant could replicate intracellularly almost indistinguishably from the wild-type strain, but was significantly impaired in its ability to induce MNGC formation; only 3% of cells infected with the *rpoS* mutant formed MNGC compared with 17% for cells infected with the wild-type strain (Utaisincharoen et al., [@B130]). However, the *rpoS* mutant was not tested for its ability to move intracellularly by actin-based motility (Table [1](#T1){ref-type="table"}). The RpoS regulon in *B. pseudomallei* has been elucidated by comparing protein expression in wild-type and *rpoS* mutant strains; 70 proteins (derived from 58 unique genes) showed differential expression of \>3-fold (*p* \< 0.05) between the two strains (Osiriphun et al., [@B88]). The proteins encoded by these differentially expressed genes included bacterial stress response and cell envelope biogenesis components as well as some putative virulence factors, including a T3SS-1 component. Thus, it is likely that RpoS regulates the expression of a *B. pseudomallei* gene(s) that is directly involved in the stimulation of cell-to-cell fusion, but the exact gene(s) has not yet been identified.

The Bsa T3SS and the effector protein BipB have also been implicated in MNGC formation; a *bipB* mutant was unable to induce MNGC formation in J774A.1 macrophage-like cells at 6 h p.i. and showed 6 to 10-fold reduced MNGC formation at later time-points (Suparak et al., [@B124]). The ability to form MNGC was restored by complementation with intact *bipB*. However, it is unclear if BipB is specifically involved in cell fusion and MNGC formation, as the *bipB* mutant was also significantly impaired for invasion of HeLa cells and was not tested for its ability to move intracellularly by actin-based motility (Table [1](#T1){ref-type="table"}).

Hcp proteins are critical components of T6SS. *B. pseudomallei* mutants with deletion of *hcp* genes from each of the six T6SS loci were tested for virulence in a hamster infection model; only the Δ*hcp1* mutant was attenuated for virulence (Burtnick et al., [@B18]). The Δ*hcp1* mutant was taken up by RAW 264.7 macrophages at a similar rate to the wild-type strain and could escape from phagosomes into the cytosol and move intracellularly by actin-based motility. Although the Δ*hcp1* mutant showed a reduced level of actin-based motility and a delayed intracellular growth phenotype, by 18 h p.i. the levels of intracellular wild-type and Δ*hcp1* mutant bacteria were indistinguishable. Importantly, no MNGC formation was observed in RAW 264.7 cells following infection with the Δ*hcp1* mutant despite high levels of intracellular bacteria (Table [1](#T1){ref-type="table"}). These data suggest that a secreted effector(s) of the T6SS is critical for the cell fusion of macrophages and for the formation of MNGC. Indeed, Burtnick et al. [@B18]) proposed that the inability of the Δ*hcp1* mutant to induce MNGC formation may lead directly to its reduced intracellular growth defect, as the fusion with nutrient rich, uninfected macrophages may be critical for the intracellular replication of *B. pseudomallei*.

A genome-wide screen for *B. pseudomallei* products which could damage macrophage cells identified a wide range of *B. pseudomallei* genes, including the putative toxin-encoding genes *bpsl0590* and *bpsl0591* (Dowling et al., [@B36]). In this analysis, the supernatants from cultures of *E. coli* containing *B. pseudomallei* genomic fragments cloned in BAC or fosmid vectors, were tested for activity against J774-2 macrophage cells. More than 110 genomic regions were identified as conferring some level of anti-macrophage activity; however, the cloned genomic fragments contained multiple genes and the anti-macrophage activity was never localized to single genes. Importantly, treatment of J774-2 cells with supernatant from *E. coli* clones containing an approximately 15 kb region containing the genes *bpsl0590* and *bpsl0591*, directly caused apoptosis and the formation of MNGC, suggesting that the putative toxins encoded by these genes may have a direct role in MNGC formation.

The MNGC formed following *B. pseudomallei* infection of macrophage-like cells show striking similarities to osteoclast cells, which are also MNGC. MNGC resulting from *B. pseudomallei* infection of RAW 264.7 cells express increased levels of mRNA encoding each of the osteoclast markers calcitonin receptor (CTR), cathepsin K (CTSK), and tartrate-resistant acid phosphatase (TRAP) compared to uninfected cells (Boddey et al., [@B12]). Interestingly, while *B. thailandensis* also induces the formation of MNGC, these cells do not express increased levels of the osteoclast markers CTR and CTSK, and show only a marginal increase in TRAP expression (Boddey et al., [@B12]). The *B. pseudomallei* gene *lfpA* (lactonase family protein A) was found to be required for maximal stimulation of expression of osteoclast markers in RAW 264.7 cells following *B. pseudomallei* infection; this gene is not present in *B. thailandensis*. Expression of *lfpA* itself was up-regulated approximately 10^7^-fold in bacteria that were in contact with RAW 264.7 cells as compared to those growing *in vitro*. A *B. pseudomallei* *lfpA* mutant was able to replicate at levels indistinguishable from the wild-type strain in RAW 264.7 macrophage-like cells and form actin-tails, but showed reduced virulence in both Syrian hamsters and BALB/c mice (Boddey et al., [@B12]; Table [1](#T1){ref-type="table"}). Taken together these data suggest that *B. pseudomallei* specifically induces the formation of MNGC through a number of mechanisms and the induction of these host cell changes may have evolved to benefit the bacteria as a niche for optimal replication and spread.

Inhibition of Macrophage Activation Facilitates Intracellular Survival
======================================================================

The ability of *B. pseudomallei* to survive and replicate in macrophages is at least in part due to the suppression of macrophage killing mechanisms, including the production of the free radical species nitric oxide (NO), although it should be noted that human macrophages produce less NO than rodent macrophages (for review see Carsillo et al., [@B21]). NO is one of the key antimicrobial molecules produced within macrophages and is important for the clearance of many intracellular pathogens, including *Leishmania*, *Salmonella*, and *Mycobacterium* (for review see Fang, [@B43]). In macrophages, NO production results from the activity of the inducible nitric oxide synthase (iNOS). Expression of iNOS is stimulated by the cytokines IFN-γ, IFN-β, TNFα, IL-1, and IL-2, and by pathogen-associated products including lipopolysaccharide (LPS) and lipoteichoic acid (Fang, [@B43]; Jacobs and Ignarro, [@B62]). However, macrophages infected with *B. pseudomallei* do not activate iNOS expression. This is due, at least in part, to the inability of *B. pseudomallei*-infected macrophages to produce IFN-γ and IFN-β, as stimulation of infected macrophages with either of these interferons results in increased iNOS expression and reduced intracellular survival of *B. pseudomallei* (Utaisincharoen et al., [@B129], [@B128]).

The secretion of IFN-β by macrophages is up-regulated in response to LPS and also infection with Gram-negative, but not Gram-positive, bacteria, suggesting that LPS is critical for production of IFN-β (Utaisincharoen et al., [@B129]). The inability of macrophages infected with *B. pseudomallei* to produce IFN-β may be a direct consequence of the LPS structure of *B. pseudomallei* (Utaisincharoen et al., [@B129]), as purified *B. pseudomallei* LPS stimulated reduced NO expression in comparison to macrophages stimulated with *E. coli* or *Salmonella enterica* serovar Typhi LPS (Utaisincharoen et al., [@B131]). Furthermore, a *B. pseudomallei* *wbiI* mutant, which is predicted to express LPS lacking O-antigen, stimulated significant levels of iNOS and IFN-β production (Arjcharoen et al., [@B6]; Figure [1](#F1){ref-type="fig"}).

Both IFN-γ and IFN-β produce a transcriptional response through the Janus kinases-signal transducers and activators of transcription (JAK--STAT) signal transduction pathway. The receptor complexes for each IFN type are related but unique (Decker et al., [@B32]) and binding of IFN to the appropriate receptor results in STAT phosphorylation and dimerization. IFN-γ binding results in STAT-1 homodimerization, whereas IFN-β results in production of phosphorylated STAT-1 homodimers and STAT-1 and STAT-2 heterodimers. These phosphorylated STAT dimers are then translocated into the nucleus where they mediate changes in expression of a range of IFN-regulated genes including iNOS. However, the suppressor of cytokine signaling (SOCS) and cytokine-inducible Src homology 2-containing (CIS) proteins can inhibit STAT phosphorylation and therefore IFN responses (Ekchariyawat et al., [@B40]; Figure [1](#F1){ref-type="fig"}). RAW 264.7 macrophages exposed to either live or killed *B. pseudomallei* showed increased expression of SOCS3 and CIS but not SOCS1 and 2 (Ekchariyawat et al., [@B40]). This activation was specifically due to the presence of intracellular *B. pseudomallei*, rather than a secondary response to macrophage cytokine production, as increased SOCS3 and CIS mRNA was observed even following pre-treatment of macrophages with the protein inhibitor cyclohexamide (Ekchariyawat et al., [@B40], [@B41]). Furthermore, up-regulation of SOCS3 mRNA was not observed in a macrophage cell line with reduced nucleotide-binding oligomerization domain-containing protein 2 (NOD2) expression, suggesting that the cytoplasmic pattern recognition receptor NOD2 is critical for SOCS3-mediated inhibition of iNOS expression (Pudla et al., [@B95]).

Evasion of Host Cell Autophagic Mechanisms by *B. pseudomallei*
===============================================================

Autophagy occurs in all eukaryotic cells and is critical for the regulated degradation of cellular components. During autophagy a portion of cytoplasm becomes enclosed within an isolation membrane (phagophore), generating a double-membrane vesicle, the autophagosome, which then, usually following initial fusion with an endosome, fuses with a lysosome. The material sequestered within the autophagosome is then degraded and the products exported to the cytosol for re-use. Autophagy is important in the context of cellular homeostasis for the removal and recycling of damaged or non-functional organelles and the destruction of certain long-lived proteins and other macromolecules (Ravikumar et al., [@B98]).

Recently, autophagy has become recognized as an important component of the eukaryotic innate immune system (Schmid and Munz, [@B105]; Ravikumar et al., [@B98]). In this context, autophagy can function as a defense mechanism against bacterial pathogens, resulting in their clearance. While some pathogens succumb to autophagic clearance and others modify autophagy to benefit their intracellular survival, it is clear that still other intracellular bacterial pathogens can evade autophagy to aid their survival (Hussey et al., [@B60]; Shahnazari and Brumell, [@B107]). Notably, two bacterial species, *L. monocytogenes* and *S. flexneri*, which can disrupt the phagosome membrane to allow escape into the cytosol, can be targeted by autophagy (Ogawa et al., [@B87]; Birmingham et al., [@B11]) when free in the cytosol.

Autophagy and *B. pseudomallei*
-------------------------------

Bacterial escape from phagosomes, and the prospect of the escaped bacteria being subject to autophagy, led us to carry out the first analyses of the interaction of *B. pseudomallei* with host cell autophagic processes. In response to infection of macrophage RAW 264.7 cells, only a subset of bacteria co-localized with the autophagy marker protein LC3 (Cullinane et al., [@B28]). When cells were treated with rapamycin, a pharmacological inducer of autophagy, bacterial co-localization with LC3 was increased significantly and bacterial survival was reduced. Thus, autophagy was implicated as part of the host defense system against *B. pseudomallei* infection, although the mechanism by which most invading bacteria avoided host autophagic attack remained obscure. Moreover, we showed that the predicted bacterial Bsa T3SS effector protein, BopA, is involved in modulating the host cell response, as *bopA* mutant bacteria showed increased co-localization with LC3 and reduced intracellular survival (Cullinane et al., [@B28]).

Recently it was shown that LC3 can be recruited directly to bacteria-containing phagosomes (Sanjuan et al., [@B102]) via a process designated LC3-associated phagocytosis (LAP; Sanjuan et al., [@B103]). In RAW 264.7 cells infected with *E. coli*, LAP was induced by LPS treatment via toll-like receptors (TLRs), and involved the rapid translocation of the autophagic proteins Beclin1 and LC3 to the bacteria-containing phagosomes, leading to an increased level of phagocytosis and bacterial killing (Sanjuan et al., [@B102]). These reports led us to assess the nature of the compartment in which intracellular *B. pseudomallei* is sequestered. Through an extensive analysis of EM images of infected cells, we demonstrated that intracellular bacteria are either free in the cytosol or sequestered in single-membrane phagosomes, but only extremely rarely contained in double-membrane autophagosomes, suggesting that LC3 is recruited to *B. pseudomallei*-containing phagosomes (Gong et al., [@B50]; Figure [2](#F2){ref-type="fig"}).

![**Possible fates of *B. pseudomallei* in infected macrophages**. Following phagocytic uptake by macrophages, bacteria are first located within phagosomes. The majority of wild-type bacteria can escape from the phagosome into the cytosol (pathway B) in a process which is largely uncharacterized but involves the Bsa T3SS. Once free in the cytosol bacteria activate BimA-mediated actin-based motility and replicate (pathway C). Potentially some cytosolic bacteria may be sequestered in canonical autophagosomes (pathway D), but the available evidence suggests that this occurs very infrequently. The autophagy marker protein LC3 can be recruited to bacteria-containing phagosomes, a process designated LC3-associated phagocytosis (LAP) which stimulates further phagosomal maturation via recruitment of other proteins, and the subsequent fusion of phagosomes with lysosomes, leading to bacterial killing (pathway A). It is possible that bacteria may escape from LAP, but definitive evidence that this occurs is presently lacking.](fmicb-02-00170-g002){#F2}

Quantitative analysis of EM images of a *bipD* mutant, lacking a functional Bsa T3SS, indicated that it displayed no escape from phagosomes at 2 and 4 h p.i. However, *bipD* mutant bacteria displayed a high level of co-localization with LC3. Furthermore, *bopA* mutant bacteria that display increased co-localization with LC3 (Cullinane et al., [@B28]) also showed reduced phagosome escape (Gong et al., [@B50]). These observations indicate that *B. pseudomallei* co-localization with LC3 occurs as a result of direct recruitment of LC3 to phagosomes that contain bacteria and is not due to engulfment of bacteria by canonical autophagosomes (Figure [2](#F2){ref-type="fig"}).

Recruitment of LC3 to phagosomes in LAP led to their rapid acidification and enhanced killing of ingested *E. coli* in RAW 264.7 cells (Sanjuan et al., [@B102], [@B103]). In our experiments, both *bipD* and *bopA* mutant bacteria showed decreased intracellular survival, enhanced co-localization with LC3 and entrapment in phagosomes (Gong et al., [@B50]). To confirm that these observations were consistent with LAP, we determined the dual co-localization of bacteria with LC3 and the lysosome marker LAMP-1. Such dual co-localization serves as a measure of the maturation of bacteria-containing LC3^+^ phagosomes by fusion with lysosomes. The percentage of bacteria co-localized with both LC3 and LAMP-1 was significantly higher for both mutants, suggesting that LC3 recruitment is associated with enhanced levels of phagolysosome maturation. Consistent with this proposal was the observation that only a very low percentage of LC3^−^ bacteria-containing phagosomes were LAMP-1^+^. On the basis of these data we propose that LC3 recruitment to *B. pseudomallei*-containing phagosomes stimulates fusion of phagosomes with lysosomes, leading to enhanced killing of the internalized bacteria. However, this hypothesis remains to be demonstrated directly.

Collectively these observations (Gong et al., [@B50]) show that LAP, rather than canonical autophagy, is the mechanism which macrophage cells use in defense against *B. pseudomallei* infection. However LAP is relatively ineffective and most bacteria escape to the cytosol where they efficiently evade capture by canonical autophagy (Figure [2](#F2){ref-type="fig"}).

Escape from autophagy occurs by a mechanism different from that used by *Shigella*
----------------------------------------------------------------------------------

*Shigella flexneri* induces membrane damage to mediate bacterial escape from the phagosome into the cytosol, where it induces actin polymerization, mediated by the bacterial IcsA (VirG) protein (Makino et al., [@B79]; Goldberg and Theriot, [@B47]). In some cell types IcsA is specifically targeted by the autophagic membrane protein Atg5, thereby inducing autophagy (Ogawa et al., [@B87]). However, *S. flexneri* secretes a T3SS effector protein, IcsB, which binds to IcsA and competitively inhibits its interaction with Atg5, thus abrogating the induction of autophagy (Ogawa et al., [@B87]). Interestingly, *B. pseudomallei* encodes the proteins BimA and BopA which have 11 and 23% amino acid identity respectively to their *S. flexneri* homologs, IcsA and IcsB.

Although BimA mediates actin-based intracellular motility of *B. pseudomallei* (Stevens et al., [@B115]), it lacks the IcsA-binding domain targeted by Atg5 (Ogawa et al., [@B87]). Thus, it would seem that BimA and IcsA are not functional counterparts in the context of autophagy evasion. Furthermore, bacterial two-hybrid analysis (our unpublished data) failed to establish an interaction between BopA and BimA, suggesting that the *B. pseudomallei* proteins do not interact in a manner comparable to their *S. flexneri* counterparts. Thus, we propose that *B. pseudomallei* evades autophagy by an alternative mechanism which currently remains unknown.

Ubiquitination-Mediated Autophagy
=================================

The specific modification of cellular proteins with polyubiquitin is a fundamental post-translational modification that occurs in all eukaryotic cells and is central to many cellular processes. Depending on the nature of the modification (K48- or K63-linked chains) polyubiquitination can result in altered functional properties, in targeting the protein for degradation by the 26S proteasome, or as shown recently, targeting of the material for lysosomal degradation by the autophagic pathway (for review see Komatsu and Ichimura, [@B72]).

Ubiquitination involves the conjugation of ubiquitin (Ub) moieties to target proteins. In mammalian cells, ubiquitination involves three enzymatic steps. Ub-activating enzymes (E1) transfer Ub to E2-conjugating enzymes, which then transfer the activated Ub to a lysine of the target protein through E3 ligases (Shabek and Ciechanover, [@B106]). Deubiquitinases are responsible for removing Ub chains from proteins (Shabek and Ciechanover, [@B106]).

The ubiquitination pathway does not operate in prokaryotes. Nevertheless, polyubiquitination has been shown in many cases to be important for regulating the host response to pathogens. Exploitation of host ubiquitination signaling pathways by pathogen effectors appears to be a common theme among bacteria (for review see Angot et al., [@B5]). A number of pathogen tactics has been described; they include effectors secreted by Type III and Type VI systems that (i) use the host ubiquitin proteasome system (UPS) to assure their own destruction; (ii) interfere with the ubiquitination level of key cellular proteins involved in innate immunity, or (iii) mimic E3 ligase subunits to manipulate the UPS to its own advantage.

A recent report suggests that, like a number of other pathogens, *B. pseudomallei* can modulate host ubiquitination to its own advantage. TssM, a secreted product of the T6SS cluster 5 encoded by the *bpss1512* gene, was identified as a virulence factor for *B. pseudomallei* (Tan et al., [@B126]). In an acute BALB/c mouse infection model, the absence of TssM in *B. pseudomallei* increased the rate of death and inflammation in infected mice. TssM was alone found to be responsible for down-regulating host inflammatory responses by interfering with the ubiquitination of critical signaling intermediates and, in turn, the activation of NF-κB. Overexpression of TssM in HEK293T cells resulted in diminished ubiquitinated forms of TNFR-associated factor-3, TNFR-associated factor-6 and IκBα. The attenuation of NF-κB activity observed in macrophages infected with wild-type *B. pseudomallei* was restored in macrophages infected with a *tssM* mutant.

BPSS1512 shares 99% identity with TssM of *B. mallei.* In an earlier study it was shown that *tssM* encodes a broad-based deubiquitinase (Shanks et al., [@B109]). Cleavage of both K48- and K63-linked ubiquitinated substrates was demonstrated in enzymatic assays. In this study no cellular substrates or phenotype in animal models could be identified. Nevertheless, collectively these studies of TssM indicate that *B. pseudomallei* is able to modulate the host ubiquitination system through the action of a secreted deubiquitinase. It remains to be seen whether other host or bacterial substrates exist for the deubiquitinase activity of TssM, or whether *B. pseudomallei* can secrete other effectors capable of modulating the host Ub-pathway. Since several target cytosolic proteins are subject to the deubiquitinase activity of TssM, it seems likely that other cytosolic host proteins may well be susceptible.

It has been suggested that Ub-mediated targeting is a general and major pathway of selective autophagy in mammals. One possible set of targets for the deubiquitinase activity of TssM, yet to be investigated, are ubiquitinated proteins associated with bacteria and recognized by the autophagic pathway. There are several reports describing the co-localization with polyubiquitin of bacteria that have escaped from the phagosome. Species include *Streptococcus pyogenes*, *L. monocytogenes*, and *Mycobacterium marinum* (for review see Shahnazari and Brumell, [@B107]). A model has been proposed in which host or bacterial proteins associated with the bacterial surface are directly ubiquitinated by the host system. However, the identity of the ubiquitinated proteins has yet to be established. An alternate model has been proposed, based on observations of *S. flexneri* infections. When *S. flexneri* disrupts the phagosome membrane to escape into the cytosol, proteins associated with membrane remnants, including TRAF6 which is involved in NF-κB signaling, are polyubiquitinated, recruit the autophagy marker LC3 and adaptor p62, and are targeted to degradation through autophagy (Dupont et al., [@B37]). The presence of both P62 and other IKK components trapped in the membrane remnants led to the suggestion that the autophagy pathway is used to regulate the activation of inflammatory responses at early time-points in infection (Dupont et al., [@B37]). Notably, in autophagy deficient (Atg5^−/−^) cells and in cells in which autophagosome maturation was blocked (ATG4B dominant negative mutant), polyubiquitinated proteins and P62 accumulated on membrane remnants, and the early inflammatory and cytokine response was exacerbated (Dupont et al., [@B37]). Our preliminary data show that *B. pseudomallei* in macrophages do not show a high degree of co-localization with poly-Ub, suggesting that the host ubiquitination pathway might be modulated at a number of levels. One intriguing possibility is that the deubiquitinase activity of the TssM effector may play a role in removing Ub from proteins associated with the bacterial surface, thereby allowing the bacteria to avoid detection and elimination from the host cell by autophagy.

*Burkholderia pseudomallei* K96243 encodes a cyclomodulin (BPSS1385) that displays 26% identity with the cycle inhibiting factor (Cif) cyclomodulin produced by enteropathogenic and enterohemorrhagic *E. coli* (Jubelin et al., [@B67]; Yao et al., [@B144]). Cif from pathogenic *E. coli* is an effector which is injected into host cells via the T3SS machinery and provokes an irreversible cytopathic effect which is characterized by G~1~ and G~2~ cell cycle arrests and reorganization of the actin network (Nougayrède et al., [@B86]; Marchès et al., [@B80]; Taieb et al., [@B125]; Samba-Louaka et al., [@B101]; Jubelin et al., [@B67]). The *B. pseudomallei* cyclomodulin, termed CHBP (for Cif homolog in *Burkholderia pseudomallei*), reveals a papain-like fold with a conserved Cys-His-Gln catalytic triad and has been shown to be a functional homolog of Cif from *E. coli* (Jubelin et al., [@B67]; Yao et al., [@B144]). Interestingly, it was recently shown that CHBP is a potent inhibitor of the eukaryotic ubiquitination pathway and specifically deamidates Gln^40^ in ubiquitin and NEDD8 (a ubiquitin-like protein) and in turn attenuates ubiquitination both *in vitro* and during *Burkholderia* infection (Cui et al., [@B27]). Notably, CHBP was recognized by melioidosis patient serum (Felgner et al., [@B44]). At present there is no evidence to connect these observations concerning CHBP with the function of host autophagic pathways.

In summary, there is a number of intriguing observations that suggest a role for ubiquitin signaling and the avoidance of host autophagy in response to infection by *B. pseudomallei*. However, a more integrated understanding must await further experimentation.

Concluding Remarks
==================

*Burkholderia pseudomallei* has evolved a large array of mechanisms to survive and replicate within eukaryotic cells, including mammalian phagocytic and non-phagocytic cells. As we have outlined in this review, the last two decades have seen significant advances in the elucidation of these mechanisms. However, much remains to be uncovered about the detailed interaction of bacterial and host cell factors at the molecular level. The apparently unique mechanism of actin-based motility in *B. pseudomallei* remains obscure. Likewise, many aspects of the roles of the three T3SS clusters in the interaction of bacterial and host cell molecules and their potential cross-talk remain to be defined. The possibility exists that the different clusters are involved in the invasion of, and replication within, different types of mammalian cells. The precise function of the six T6SS clusters also requires further investigation. While it is clear that most *B. pseudomallei* in cells are able to escape autophagic attack, the mechanisms are presently unknown. The possibility of host ubiquitination of the bacterial cell surface and whether *B. pseudomallei* possesses strategies to combat this process are currently under investigation.
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